Laura Jenkins
Affiliations: | 2014-2018 | Chemistry and Biochemistry | University of South Carolina, Columbia |
Google:
"Laura Jenkins"Parents
Sign in to add mentor| Mythreye Karthikeyan | grad student | 2014-2018 | University of South Carolina, Columbia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang X, Wang Y, Supekar S, et al. (2023) Pro-phagocytic function and structural basis of GPR84 signaling. Nature Communications. 14: 5706 |
| Zhang X, Wang Y, Supekar S, et al. (2023) Pro-phagocytic function and structural basis of GPR84 signaling. Research Square |
| Weickhardt AJ, Lau DK, Hodgson-Garms M, et al. (2022) Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer. Bmc Cancer. 22: 478 |
| Choi A, Jenkins L, Mythreye K. (2021) Elucidating the Impact of Betaglycan Glycosaminoglycan Chain Modification on Ectodomain Shedding and Cell Signaling in Ovarian Cancer The Faseb Journal. 35 |
| Binti Mohd Amir NAS, Mackenzie AE, Jenkins L, et al. (2018) Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35. Journal of Immunology (Baltimore, Md. : 1950) |
| Serrao A, Jenkins LM, Chumanevich AA, et al. (2018) Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer. Oncogene |
| Singh P, Jenkins LM, Horst B, et al. (2018) Inhibin is a novel paracrine factor for tumor angiogenesis and metastasis. Cancer Research |
| Jenkins LM, Horst B, Lancaster CL, et al. (2017) Dually modified transmembrane proteoglycans in development and disease. Cytokine & Growth Factor Reviews |
| Chüeh AC, Tse JW, Dickinson M, et al. (2017) ATF3 repression of BCL-XL determines apoptotic sensitivity toHDAC inhibitors across tumour types. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Singh P, Jenkins L, O'Connell K, et al. (2017) Abstract MIP-063: DEFINING NOVEL PARACRINE FUNCTIONS FOR INHIBIN IN OVARIAN CANCER Clinical Cancer Research. 23 |